Related Experiment Videos

Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and

A Mekontso-Dessap1, M Kirsch, C Brun-Buisson

  • 1Service de Chirurgie Thoracique et Cardiovasculaire, Centre Hospitalo-Universitaire Henri Mondor, Créteil, France.

Insights

Poststernotomy mediastinitis (PSM) caused by methicillin-resistant Staphylococcus aureus (MRSA) leads to significantly poorer outcomes compared to methicillin-susceptible Staphylococcus aureus (MSSA). MRSA is an independent risk factor for mortality in PSM patients.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Cardiothoracic Surgery

Background:

  • Poststernotomy mediastinitis (PSM) is a serious complication following cardiac surgery.
  • Staphylococcus aureus is a common causative agent of PSM.
  • Distinguishing outcomes between methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains is crucial for treatment strategies.

Purpose of the Study:

  • To compare the clinical outcomes of PSM caused by MRSA versus MSSA.
  • To identify risk factors associated with mortality in S. aureus PSM.

Main Methods:

  • Retrospective review of 41 patients with S. aureus PSM treated with closed drainage.
  • Comparison of perioperative characteristics, survival rates, and PSM-related complications between MRSA and MSSA groups.
  • Logistic regression analysis to determine independent risk factors for mortality.

Main Results:

  • No significant difference in perioperative characteristics between MRSA and MSSA groups.
  • Significantly lower actuarial survival rates in patients with MRSA PSM compared to MSSA PSM (P=.04).
  • Higher rates of PSM-related death and treatment failure in the MRSA group (P=.03 and P=.02, respectively).
  • MRSA identified as the sole independent risk factor for overall mortality.

Conclusions:

  • The clinical outcome of PSM caused by MRSA is significantly poorer than that caused by MSSA.
  • MRSA infection is associated with increased mortality and treatment failure in PSM.
  • Early identification and targeted treatment of MRSA are critical for improving PSM patient survival.

Related Concept Videos